Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PROC | US
-0.08
-3.52%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
04/10/2024
2.16
2.16
2.16
2.16
Procaps Group S.A. develops produces and markets pharmaceutical solutions worldwide. The company formulates manufactures and markets branded prescription drugs in various therapeutic areas including feminine care products pain relief skin care digestive health growth and development cardiology vision care central nervous system and respiratory. It also provides drugs for hospital use such as antibiotic blood clot personal protective equipment immunosuppressant oncology and analgesics products. In addition the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas including gastrointestinal skin care cough and cold analgesics urological vitamins minerals and supplements in the categories of antibiotics anti-infective anti-parasitic cardiovascular feminine care cutaneous antimycotic pain killers gastro intestinal hormonals metabolic endocrine nervous system ophthalmic osteoarticular respiratory diet supplements and vitamins and minerals. Further it provides blood glucose meters telemonitoring products oral anti-diabetics products cosmeceuticals insulin delivery systems and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg Luxembourg.
View LessLow Market Beta (-0.4 to 0.8)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
144.8%1 month
107.6%3 months
73.0%6 months
65.7%4.37
81.30
6.39
-
-
4.18
1.25
-
57.06M
243.84M
243.84M
-
11.13
-63.70
7.30
37.37
3.99
0.03
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.61
Range1M
0.61
Range3M
1.13
Rel. volume
0.17
Price X volume
2.87K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.04 | 267.99M | -0.33% | n/a | 0.27% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 4.92 | 262.25M | 2.71% | n/a | 39.24% |
Solid Biosciences Inc | SLDB | Drug Manufacturers-Specialty & Generic | 6.58 | 253.96M | -0.60% | n/a | 13.09% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.82 | 175.62M | 3.68% | n/a | -113.78% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 5.38 | 166.05M | 8.25% | 19.80 | 241.85% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.138 | 137.72M | 5.83% | n/a | 1.10% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.97 | 137.67M | 2.07% | n/a | 1.07% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.42 | 117.01M | -4.70% | n/a | 8.14% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.7699 | 112.70M | 2.15% | n/a | 36.36% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.8874 | 110.64M | 0.40% | n/a | -148.05% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 6.74 | 123.04M | -2.46% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Culp Inc | CULP | Textile Manufacturing | 5.95 | 74.32M | -2.30% | n/a | 11.29% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6199 | 5.90M | 6.82% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.33 | 5.20M | 0.03% | n/a | 0.97% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 4.18 | 17.21 | Cheaper |
Ent. to Revenue | 1.25 | 334.38 | Cheaper |
PE Ratio | 4.37 | 26.92 | Cheaper |
Price to Book | 6.39 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 73.02 | 68.34 | Par |
Debt to Equity | - | -1.00 | - |
Debt to Assets | - | 0.48 | - |
Market Cap | 243.84M | 5.31B | Emerging |